The reliability of EUS for the diagnosis of chronic pancreatitis: Interobserver agreement among experienced endosonographers
Indiana University-Purdue University Indianapolis, Indianapolis, Indiana, United States Gastrointestinal Endoscopy
(Impact Factor: 5.37).
04/2001; 53(3):294-9. DOI: 10.1016/S0016-5107(01)70401-4
Endoscopic ultrasound (EUS) is a minimally invasive, low risk method of diagnosis for chronic pancreatitis (CP). The degree to which endosonographers agree on the features and diagnosis of CP is unknown. For EUS to be considered an accurate test for CP, there must be good interobserver agreement.
Forty-five pancreatic EUS examinations were videotaped by 3 experienced endosonographers. Examinations from 33 patients with suspected CP based on typical symptoms, as well as 12 control patients without suspected CP, were included. Eleven experienced endosonographers ("experts") who were blinded to clinical information independently evaluated all videotaped examinations for the presence of CP and the following 9 validated features of CP: echogenic foci, strands, lobularity, cysts, stones, duct dilatation, duct irregularity, hyperechoic duct margins, and visible side branches. The experts also ranked (most to least) which features they believed to be the most indicative of CP. Interobserver agreement was expressed as the kappa (kappa) statistic.
There was moderately good overall agreement for the final diagnosis of CP (kappa = 0.45). Agreement was good for individual features of duct dilatation (kappa = 0.6) and lobularity (kappa = 0.51) but poor for the other 7 features (kappa < 0.4). The expert panel had consensus or near consensus agreement (greater than 90%) on 206 of 450 (46%) individual EUS features including 22 of 45 diagnoses of CP. Agreement on the final diagnosis of CP was moderately good for those trained in third tier fellowships (kappa = 0.42 +/- 0.03) and those with more than 1100 lifetime pancreatic EUS examinations (kappa = 0.46 +/- 0.05). The presence of stones was regarded as the most predictive feature of CP by all endosonographers, followed by visible side branches, cysts, lobularity, irregular main pancreatic duct, hyperechoic foci, hyperechoic strands, main pancreatic duct dilatation, and main duct hyperechoic margins. The most common diagnostic criterion for the diagnosis of CP was the total number of features (median 4 or greater, range 3 or greater to 5 or greater).
EUS is a reliable method for the diagnosis of chronic pancreatitis with good interobserver agreement among experienced endosonographers. Agreement on the EUS diagnosis of chronic pancreatitis is comparable to other commonly used endoscopic procedures such as bleeding ulcer stigmata and computed tomography of the brain for stroke localization and better than the physical diagnosis of heart sounds.
Available from: Richard Zubarik
- "However, it can sometimes be difficult to distinguish EUS findings of chronic pancreatitis from normal variation in echogenicity of the pancreas, and it is not always clear how these findings should change patient management. Also, EUS exams for chronic pancreatitis are subject to interobserver variability.16,17 Ideally The Rosemont classification system could improve identification of patients with chronic pancreatitis, and help guide therapy. "
[Show abstract] [Hide abstract]
ABSTRACT: The Rosemont classification system was designed to standardize the endosonographic assessment of chronic pancreatitis. To determine whether the Rosemont classification system can predict the response to pancreatic enzyme supplementation in patients undergoing endoscopic ultrasound (EUS) evaluation of suspected chronic pancreatitis.
Sixty-five patients were included with abdominal pain undergoing endosonography for suspected chronic pancreatitis were included. Patients completed a questionnaire for evaluation of their abdominal pain. Group 1 (n=13) had EUS findings consistent with or suggestive of chronic pancreatitis. Group 2 (n=45) had EUS findings that were normal or indeterminate in the Rosemont classification system. Patients were given pancreatic enzyme supplementation and then given a follow-up pain questionnaire for a mean of 37 days subsequent to EUS regarding the change in pain.
Group 1 patients were more likely to have a response to pancreatic enzymes (62% vs 24%, p=0.012) and a decrease in their pain scale ratings (2.62 vs 0.29, p=0.01). Computed tomography findings of chronic pancreatitis and narcotic use did not predict the response to pancreatic enzyme supplementation. The individual Rosemont criteria of hyperechoic foci with shadowing (p=0.03), lobularity (p=0.02), and stranding (p=0.001) were associated with improvement of pain after treatment.
The Rosemont classification system can identify patients who are more likely to have improvement in abdominal pain after treatment with pancreatic enzyme supplementation.
[Show abstract] [Hide abstract]
ABSTRACT: Since the joining of ultrasonographic and endoscopic technologies in 1980, there has been tremendous advancement in the use of endoscopic ultrasound (EUS). Initially EUS was used mainly to study the anatomic appearance of digestive organs. In the 1990s, with the development of the charge-coupled device, thinner, more flexible scopes were developed that simplified imaging for the endo- sonographer and improved patient safety. With the development of linear array EUS scopes, biopsies could be performed utilizing fine needle aspiration. Currently, several therapeutic techniques, which were formerly performed through radiologic or surgical procedures, are being safely done with EUS. These include celiac plexus neuroly- sis and endoscopic drainage of pancreatic cysts. With the advent of miniprobe technology, better delineation of the wall of the gastro- intestinal tract can be obtained, facilitating endoscopic mucosal resection. Novel therapeutic uses for EUS are constantly emerging. This article describes the various extraintestinal applications of EUS that have been developed in the last 25 years. More gastroenterolo- gists need training in order to utilize this challenging technology and improve patient access in the local community setting.
Available from: wjgnet.com
[Show abstract] [Hide abstract]
ABSTRACT: C h r o n i c p a n c r e a t i t i s ( C P ) i s a p e r s i s t e n t i n f l a m m a t o r y d i s e a s e c h a r a c t e r i z e d b y irreversible morphological changes in the
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.